• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用荧光引导的多次采样解析胶质母细胞瘤微环境中的肿瘤内异质性。

Dissecting Intra-tumor Heterogeneity in the Glioblastoma Microenvironment Using Fluorescence-Guided Multiple Sampling.

机构信息

The Brain Tumor Translational Laboratory, Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.

University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.

出版信息

Mol Cancer Res. 2023 Aug 1;21(8):755-767. doi: 10.1158/1541-7786.MCR-23-0048.

DOI:10.1158/1541-7786.MCR-23-0048
PMID:37255362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10390891/
Abstract

The treatment of the most aggressive primary brain tumor in adults, glioblastoma (GBM), is challenging due to its heterogeneous nature, invasive potential, and poor response to chemo- and radiotherapy. As a result, GBM inevitably recurs and only a few patients survive 5 years post-diagnosis. GBM is characterized by extensive phenotypic and genetic heterogeneity, creating a diversified genetic landscape and a network of biological interactions between subclones, ultimately promoting tumor growth and therapeutic resistance. This includes spatial and temporal changes in the tumor microenvironment, which influence cellular and molecular programs in GBM and therapeutic responses. However, dissecting phenotypic and genetic heterogeneity at spatial and temporal levels is extremely challenging, and the dynamics of the GBM microenvironment cannot be captured by analysis of a single tumor sample. In this review, we discuss the current research on GBM heterogeneity, in particular, the utility and potential applications of fluorescence-guided multiple sampling to dissect phenotypic and genetic intra-tumor heterogeneity in the GBM microenvironment, identify tumor and non-tumor cell interactions and novel therapeutic targets in areas that are key for tumor growth and recurrence, and improve the molecular classification of GBM.

摘要

由于其异质性、侵袭性和对化疗和放疗的不良反应,成人中最具侵袭性的原发性脑肿瘤——胶质母细胞瘤(GBM)的治疗极具挑战性。因此,GBM 不可避免地会复发,只有少数患者在诊断后能存活 5 年。GBM 的特征是广泛的表型和遗传异质性,形成了多样化的遗传景观和亚克隆之间的生物相互作用网络,最终促进肿瘤生长和治疗耐药性。这包括肿瘤微环境中的时空变化,影响 GBM 中的细胞和分子程序以及治疗反应。然而,在时空水平上剖析表型和遗传异质性极具挑战性,而且单个肿瘤样本的分析无法捕捉 GBM 微环境的动态。在这篇综述中,我们讨论了 GBM 异质性的当前研究,特别是荧光引导多次采样在剖析 GBM 微环境中肿瘤内表型和遗传异质性、识别肿瘤和非肿瘤细胞相互作用以及新的治疗靶点方面的实用性和潜在应用,这些靶点对于肿瘤生长和复发的关键区域至关重要,并提高了 GBM 的分子分类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e18/10390891/64ffb7a0b175/755fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e18/10390891/8b7788500100/755fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e18/10390891/b6111b59fcfc/755fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e18/10390891/64ffb7a0b175/755fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e18/10390891/8b7788500100/755fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e18/10390891/b6111b59fcfc/755fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e18/10390891/64ffb7a0b175/755fig3.jpg

相似文献

1
Dissecting Intra-tumor Heterogeneity in the Glioblastoma Microenvironment Using Fluorescence-Guided Multiple Sampling.利用荧光引导的多次采样解析胶质母细胞瘤微环境中的肿瘤内异质性。
Mol Cancer Res. 2023 Aug 1;21(8):755-767. doi: 10.1158/1541-7786.MCR-23-0048.
2
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.胶质母细胞瘤中的分子异质性和免疫抑制微环境。
Front Immunol. 2020 Jul 17;11:1402. doi: 10.3389/fimmu.2020.01402. eCollection 2020.
3
Oligodendrocyte Progenitor Cells in the Tumor Microenvironment.肿瘤微环境中的少突胶质前体细胞。
Adv Exp Med Biol. 2020;1234:107-122. doi: 10.1007/978-3-030-37184-5_8.
4
Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.单细胞 RNA 测序揭示复发性脑胶质瘤的肿瘤异质性、微环境和耐药机制。
Cancer Sci. 2023 Jun;114(6):2609-2621. doi: 10.1111/cas.15773. Epub 2023 Mar 10.
5
The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma.胶质母细胞瘤中治疗抵抗和肿瘤复发的多方面因素。
Cells. 2021 Feb 24;10(3):484. doi: 10.3390/cells10030484.
6
"Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing.“放大”胶质母细胞瘤:单细胞 RNA 测序时代对肿瘤异质性及其临床意义的理解。
Neurosurgery. 2021 Feb 16;88(3):477-486. doi: 10.1093/neuros/nyaa305.
7
Macrophages and microglia: the cerberus of glioblastoma.巨噬细胞和小胶质细胞:胶质母细胞瘤的三头犬。
Acta Neuropathol Commun. 2021 Mar 25;9(1):54. doi: 10.1186/s40478-021-01156-z.
8
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.胶质母细胞瘤诱导的小胶质细胞在患者肿瘤和患者来源的原位异种移植物中向具有吞噬细胞和树突状细胞样特征的异质表型状态转变。
Genome Med. 2024 Apr 2;16(1):51. doi: 10.1186/s13073-024-01321-8.
9
Autophagy in glioblastoma: A mechanistic perspective.胶质母细胞瘤中的自噬:一种机制观点。
Int J Cancer. 2024 Aug 15;155(4):605-617. doi: 10.1002/ijc.34991. Epub 2024 May 8.
10
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective.从三维全肿瘤角度看胶质母细胞瘤的演变和异质性。
Cell. 2024 Jan 18;187(2):446-463.e16. doi: 10.1016/j.cell.2023.12.013.

引用本文的文献

1
Illuminating radiogenomic signatures in pediatric-type diffuse gliomas: insights into molecular, clinical, and imaging correlations. Part I: high-grade group.小儿型弥漫性胶质瘤中具有启发性的放射基因组特征:分子、临床和影像相关性洞察。第一部分:高级别组。
Radiol Med. 2025 Aug 25. doi: 10.1007/s11547-025-02078-9.
2
Treatment Resistant Persister Cells Exploit Macrophage Lipid Metabolism to Sustain Glioblastoma Growth.耐药性持留细胞利用巨噬细胞脂质代谢来维持胶质母细胞瘤的生长。
bioRxiv. 2025 Jun 10:2025.06.07.658345. doi: 10.1101/2025.06.07.658345.
3
Differential response of patient-derived primary glioblastoma cells to metabolic and adhesion inhibitors.

本文引用的文献

1
Transcriptome analysis reveals tumor microenvironment changes in glioblastoma.转录组分析揭示了胶质母细胞瘤中肿瘤微环境的变化。
Cancer Cell. 2023 Apr 10;41(4):678-692.e7. doi: 10.1016/j.ccell.2023.02.019. Epub 2023 Mar 9.
2
Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects.单细胞 RNA 测序和空间转录组学揭示胶质母细胞瘤中具有促肿瘤作用的癌相关成纤维细胞。
J Clin Invest. 2023 Mar 1;133(5):e147087. doi: 10.1172/JCI147087.
3
Single-cell spatial immune landscapes of primary and metastatic brain tumours.
患者来源的原发性胶质母细胞瘤细胞对代谢和黏附抑制剂的差异反应。
Clin Exp Med. 2025 Jun 26;25(1):220. doi: 10.1007/s10238-025-01736-6.
4
Exploring the immune environment of glioblastoma through single-cell RNA sequencing in humanized mouse models.通过人源化小鼠模型中的单细胞RNA测序探索胶质母细胞瘤的免疫环境。
bioRxiv. 2025 May 22:2025.05.17.654526. doi: 10.1101/2025.05.17.654526.
5
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation.基于新抗原的免疫疗法:通过发现与创新推动癌症和胶质母细胞瘤治疗的精准医学发展。
Explor Target Antitumor Ther. 2025 Apr 27;6:1002313. doi: 10.37349/etat.2025.1002313. eCollection 2025.
6
Harnessing the Power of Metabolomics for Precision Oncology: Current Advances and Future Directions.利用代谢组学助力精准肿瘤学:当前进展与未来方向
Cells. 2025 Mar 10;14(6):402. doi: 10.3390/cells14060402.
7
Radiomics-Based Machine Learning with Natural Gradient Boosting for Continuous Survival Prediction in Glioblastoma.基于影像组学的机器学习与自然梯度提升用于胶质母细胞瘤的连续生存预测
Cancers (Basel). 2024 Oct 26;16(21):3614. doi: 10.3390/cancers16213614.
8
Assessing RNA-Seq Workflow Methodologies Using Shannon Entropy.使用香农熵评估RNA测序工作流程方法
Biology (Basel). 2024 Jun 28;13(7):482. doi: 10.3390/biology13070482.
9
Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT.硼替佐米(BSH)和硼苯丙氨酸(BPA)作为癌症中微子俘获治疗(NCT)硼供体的评价:对未来用于 NCT 的新型硼供体临床评价的更新和指导。
Cancer Commun (Lond). 2024 Aug;44(8):893-909. doi: 10.1002/cac2.12582. Epub 2024 Jul 8.
10
Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma.人类胶质母细胞瘤脑室下区的单核及空间图谱
bioRxiv. 2024 Apr 27:2024.04.24.590852. doi: 10.1101/2024.04.24.590852.
原发性和转移性脑肿瘤的单细胞空间免疫图谱。
Nature. 2023 Feb;614(7948):555-563. doi: 10.1038/s41586-022-05680-3. Epub 2023 Feb 1.
4
Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy.胶质母细胞瘤中的巨噬细胞和小胶质细胞:异质性、可塑性和治疗。
J Clin Invest. 2023 Jan 3;133(1):e163446. doi: 10.1172/JCI163446.
5
A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets.治疗下胶质母细胞瘤进化的单细胞图谱揭示了细胞内在和细胞外在的治疗靶点。
Nat Cancer. 2022 Dec;3(12):1534-1552. doi: 10.1038/s43018-022-00475-x. Epub 2022 Dec 20.
6
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy.新型胶质母细胞瘤肿瘤微环境亚型的鉴定、验证及生物学特征:对精准免疫治疗的意义
Ann Oncol. 2023 Mar;34(3):300-314. doi: 10.1016/j.annonc.2022.11.008. Epub 2022 Dec 6.
7
Immunotherapy approaches for adult glioma: knowledge gained from recent clinical trials.成人脑胶质瘤的免疫治疗方法:来自近期临床试验的研究进展。
Curr Opin Neurol. 2022 Dec 1;35(6):803-813. doi: 10.1097/WCO.0000000000001118. Epub 2022 Oct 21.
8
Turning on the light for brain tumor surgery: A 5-aminolevulinic acid story.脑肿瘤手术中的“明灯”:5-氨基酮戊酸的故事。
Neuro Oncol. 2022 Nov 2;24(Suppl 6):S52-S61. doi: 10.1093/neuonc/noac191.
9
Characterizing the biology of primary brain tumors and their microenvironment via single-cell profiling methods.通过单细胞分析方法对原发性脑肿瘤及其微环境的生物学特性进行分析。
Neuro Oncol. 2023 Feb 14;25(2):234-247. doi: 10.1093/neuonc/noac211.
10
Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity.胶质母细胞瘤中的癌细胞自噬、重编程的巨噬细胞和重塑的血管触发肿瘤免疫。
Cancer Cell. 2022 Oct 10;40(10):1111-1127.e9. doi: 10.1016/j.ccell.2022.08.014. Epub 2022 Sep 15.